CSL Limited
CSL
株式のランク
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
株価
$137.83
時価総額
$66.14B
変化（1日）
0.87%
変化（1年）
-3.78%
国
AU
取引 CSL Limited (CSL)
カテゴリー
Healthcare
CSL Limited（CSL）の株価履歴
終値の最高値: $130.93 （2026-10-01）
終値の最安値: $0.58 （1994-05-01）
終値の最安値: $0.58 （1994-05-01）
CSL Limited の株価履歴（1994 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -11.03% |
| 2025 | -33.22% |
| 2024 | -3.40% |
| 2023 | -7.34% |
| 2022 | -5.55% |
| 2021 | -4.35% |
| 2020 | 13.64% |
| 2019 | 48.92% |
| 2018 | 19.64% |
| 2017 | 51.86% |
| 2016 | -2.99% |
| 2015 | 3.42% |
| 2014 | 17.66% |
| 2013 | 7.48% |
| 2012 | 72.89% |
| 2011 | -9.64% |
| 2010 | 27.38% |
| 2009 | 31.88% |
| 2008 | -30.73% |
| 2007 | 91.54% |
| 2006 | 59.34% |
| 2005 | 39.55% |
| 2004 | 69.88% |
| 2003 | 10.97% |
| 2002 | -54.53% |
| 2001 | 23.69% |
| 2000 | 47.80% |
| 1999 | 54.18% |
| 1998 | 35.94% |
| 1997 | 57.11% |
| 1996 | 56.41% |
| 1995 | 57.26% |
| 1994 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.31 | 8.49% |
CH
|
|
| $263.80 | -7.32% |
BE
|
